Replies to post #158232 on Biotech Values

[vinmantoo]

porkchop, the truth is the truth. Sorry if you don't like it but you have to face it. There was no control in the Bavi phase II NSCLC trial because it was corrupted. Apparently you are unclear as to what constitutes a control in a trial. It can be 1) a comparison of your drug to a placebo, 2) comparing your drug to another drug and 3) comparing your drug + another drug to the other drug alone. The small (corrupted) phase II NSCLC trial using Bavi has none of these, hence has NO control for comparison. Those are the facts whether or not you want to acknowledge them.

PPHM outright lied in the quarterly report when they said the following

""Promising 60% improvement in median overall survival (OS) in the 3mg/kg bavituximab plus docetaxel arm compared to the control arm and that bavituximab was well-tolerated with no significant differences in adverse events between the trial arms. ""

There is NO control arm in the NSCLC trial due to the patient mix-up.

Now go back to the PPHM board where you spin conspiracy theories, and and fantasize without restriction. I will NOT respond to you again.